Physician profile
Brandt M Aymond
NPI 1154979078
$1,755.79
in general payments reported to CMS, 2019-2025
12 companies · $402 in 2025
The $402 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $30.69 · 2022: $75.29 · 2023: $647 · 2024: $601 · 2025: $402.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,650.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,649.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Regeneron Healthcare Solutions, INC. | $386.53 | 2022-2025 | Dupixent |
| Glaxosmithkline, LLC. | $357.57 | 2022-2025 | Nucala, Trelegy Ellipta |
| Genzyme Corporation | $307.53 | 2023-2025 | |
| Optinose US, INC. | $164.61 | 2022-2024 | |
| Abbvie INC. | $127.87 | 2023-2025 | |
| Hikma Pharmaceuticals USA | $121.39 | 2023-2024 | Ryaltris |
| Pfizer INC. | $114.91 | 2023-2024 | |
| Lundbeck LLC | $66.64 | 2024-2025 | Vyepti |
| Astrazeneca Pharmaceuticals LP | $43.48 | 2024-2025 | Airsupra |
| Genentech USA, INC. | $30.69 | 2021 | |
| Novartis Pharmaceuticals Corporation | $18.31 | 2023 | |
| Biohaven Pharmaceutical Holding Company LTD. | $16.26 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brandt Aymond listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.